Valance Washington/LinkedIn; Taras Oleksyk/EEBG; Walter Wolfsberger/The Oakland Post
Feb 9, 2026, 14:22
Valance Washington: An Evidence-Based View on Emerging Therapies for Thrombotic Disorders
Valance Washington, Professor at Oakland University, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Our latest publication — a letter in the Journal of Thrombosis and Thrombolysis offering an evidence-based view on emerging therapies for thrombotic disorders.
A quick read for clinicians and researchers navigating these challenges.”
Title: Subject: letter to the editor: platelet single-cell RNA sequencing
Authors: Valance Washington, Walter Wolfsberger, Taras Oleksyk
Read the Full Article on Journal of Thrombosis and Thrombolysis
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 6, 2026, 04:33Hessam Kakavand: Rethinking Thrombotic Risk in Modern Cancer Therapy
-
Oct 6, 2026, 04:07Moussa Zein Aldine: Acute Coronary Syndrome Every Minute Matters
-
Oct 6, 2026, 03:13Patrick Taylor: Glow Stack Trend What the Evidence Really Shows
-
Oct 6, 2026, 02:59Preventing Hospital Associated Venous Thromboembolism – Thrombosis Canada
-
Oct 6, 2026, 02:42Treatment of Iron Deficiency With and Without Anemia – American Society of Hematology
-
Oct 6, 2026, 02:36Mouna Sassi: When Clinical and Laboratory Perspectives Meet in Thrombosis Care
-
Oct 6, 2026, 02:35Lucia Stefanini: Platelet Dysfunction and Oxidized Phospholipids in MASLD
-
Oct 6, 2026, 02:18Pablo Corral: Association of Lp(a) With Coronary Atherosclerosis and CV Events
-
Oct 5, 2026, 22:55Steve Humphreys: A Big Thank You to BSHT for Providing Me With a Recent Skills Exchange Award